Sihuan Pharma's Polycaprolactone Microsphere Filler Gains NMPA Approval
CompanyMedical Device

Sihuan Pharma’s Polycaprolactone Microsphere Filler Gains NMPA Approval

Shionogi Partners with Link Medical for Cefiderocol Development in Australia and New Zealand
CompanyDeals

Shionogi Partners with Link Medical for Cefiderocol Development in Australia and New Zealand

WuXi XDC Partners with MABSOFT to Advance Innovative ADC Development
CompanyDeals

WuXi XDC Partners with MABSOFT to Advance Innovative ADC Development

Guojian Qingke Biomedical Gains NMPA Approval for 3D MSCs in Stroke Trials
CompanyDrug

Guojian Qingke Biomedical Gains NMPA Approval for 3D MSCs in Stroke Trials

Gan & Lee Pharmaceuticals Secures Pakistan Approval for Insulin Glargine Cartridge
CompanyDrug

Gan & Lee Pharmaceuticals Secures Pakistan Approval for Insulin Glargine Cartridge

Biogen's BIIB080 Receives FDA Fast Track Designation for Alzheimer's
CompanyDrug

Biogen’s BIIB080 Receives FDA Fast Track Designation for Alzheimer’s

NMPA Reduces Influenza Vaccine Batch Release Time to 45 Working Days
Policy / Regulatory

NMPA Reduces Influenza Vaccine Batch Release Time to 45 Working Days

Pfizer and Flagship Pioneering Collaborate on AI-Driven Drug Development
CompanyDeals

Pfizer and Flagship Pioneering Collaborate on AI-Driven Drug Development

Nurix Therapeutics Expands Sanofi Partnership with Undisclosed TPD Program
CompanyDeals

Nurix Therapeutics Expands Sanofi Partnership with Undisclosed TPD Program

Jiangxi Rimag Lists CT Chest Lesion Data on Shanghai Data Exchange
Company

Jiangxi Rimag Lists CT Chest Lesion Data on Shanghai Data Exchange

Novartis' Fabhalta Approved in China for C3 Glomerulopathy
CompanyDrug

Novartis’ Fabhalta Approved in China for C3 Glomerulopathy

Shionogi Submits Rolling NDA for Ensitrelvir in US for COVID-19 Prophylaxis
CompanyDrug

Shionogi Submits Rolling NDA for Ensitrelvir in US for COVID-19 Prophylaxis